Allezoe Medical Holdings (ALZM) Clarifies Policy on Releasing Information

BOCA RATON, FLORIDA--(Marketwire - March 9, 2012) - Allezoe Medical Holdings, Inc. ALZM announced today that it has been receiving multiple, repeated telephone calls and emails demanding that the Company issue press releases, or demanding to know when press releases will be issued. The calls have been made to Michael Gelmon, CEO and to the offices of the Company's corporate counsel.

Allezoe CEO Michael Gelmon stated: "Allezoe Medical Holdings does not engage in artificial inflation of its common stock price or volume by issuing questionable press releases, retaining stock promoters and similar activity. Management is focused on funding and growing its medical technologies, seeking and negotiating appropriate acquisitions, and otherwise building the company. Press releases and other dissemination of company information is done only when there is material information to be released, and in accordance with the rules and regulations applicable to the Company, including the SEC's Regulation FD."

The Company is issuing this release so that interested parties are informed that the Company will only issue press releases when appropriate material information is required to be released, and will never respond to demands for the issuance of press releases, or to inquiries about when press releases are going to be issued.

Mr. Gelmon further stated: "The intense pressure on management to release information, whether appropriate or not, has now escalated to physical threats and demands against myself and other members of management and consultants, as a result of which we have begun to record the threats and the telephone numbers of the sources of these threats for action by the appropriate authorities. It is unfortunate that outside, unaffiliated groups may have engaged in inappropriate activity in our stock in the past, the result of which, among other things, caused a significant drop in our stock trading price, which then limited our ability to complete a major working capital funding that had already been negotiated. No one affiliated with the Company, including its management and consultants, has engaged in any stock selling and our majority shareholder, Elan Health Services, Inc. has not sold, and cannot sell, any stock in the market due to its affiliated status. Management is focused on acquisitions and the development of our acquired technologies, and will release information on these activities only as and when it is appropriate."

About Allezoe Medical Holdings

Allezoe Medical Holdings, Inc. is a holding company focused on acquiring the most high quality and in-demand medical products, solutions and services. Whether through diagnosis, treatment, or medical research itself, Allezoe is interested in companies that are making a striking difference in the healthcare system through technology and treatments for health issues that affect large populations. For more information, please visit www.allezoe.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. The Company assumes no obligation to update the statements contained in this release except as required by applicable securities disclosure rules. The Company's SEC filings are available at http://www.sec.gov.